Friday, March 29, 2024
Homebiotech and pharmaceuticalsFormer Allergan CEO continues battle with Pershing

Former Allergan CEO continues battle with Pershing

After his bitter, 8½-month battle with Valeant and activist hedge fund Pershing Square last year, former Allergan chief David Pyott is not going quietly.

"I've visited many members of Congress, doing my best to ensure whatever oversight is possible," Pyott said at a hearing Thursday by the Senate Permanent Subcommittee on Investigations on the U.S. tax code.

RELATED ARTICLES
- Advertisment -

Most Popular